AIM Vaccine Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-315.00
-2,509.00
-504.00
-731.00
545.00
177.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
151.00
123.00
-102.00
-397.00
-426.00
109.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
55.00
-217.00
-160.00
110.00
230.00
364.00
Cash Flow from Investing Activities
-184.00
-284.00
-989.00
-1,624.00
-1,257.00
-882.00
Cash Flow from Financing Activities
37.00
453.00
1,151.00
962.00
1,873.00
357.00
Net Cash Inflow / Outflow
-90.00
-46.00
-1.00
-552.00
846.00
-160.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
-2.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AIM Vaccine Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-315.203387045201
2568.69216914088
-2,883.00
-112.27%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
151.381501338153
593.432572613316
-442.00
-74.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
55.6380307019574
3836.69086872597
-3,781.00
-98.55%
Cash Flow from Investing Activities
-184.275768495894
-2044.38211915875
1,860.00
90.99%
Cash Flow from Financing Activities
37.5412505467156
-2254.92863135853
2,291.00
101.66%
Net Cash Inflow / Outflow
-90.5565437736544
-526.254063331742
436.00
82.79%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.539943473567203
-63.6341815404271
63.00
100.85%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 125.58% vs -35.40% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
55.64
-217.51
125.58%






